About AIOLOZ
Aioloz is a service provided by KBI Korean Biomedical Research Institute, a clinical and non-clinical testing organization with expertise and precision.

As an institute specializing in the professional and accurate clinical and non-clinical trials, KBI evaluates the effectiveness and safety of cosmetics, functional food, medical devices, and pharmaceuticals. KBI performs human skin study and official medical device test hospital study based on responsibilities of dermatologists, plastic surgeons, pediatricians, endocrinologists, anesthesiologists, and dentists. KBI is also in charge of approval and accreditation of KFDA, FDA, CE/MDR, etc. It also collects test subjects quickly based on optimal test design and provides fast, objective, and precise test report based on systematic management of compliance and abnormal reaction.

Why Do You Have to be Careful About
Choosing Clinical Institute?

Nowadays, consumers check product reviews and product ingredients for smart consumption. So, consumers pay attention to the objective verifiable results as they check reviews and ingredients. Since clinical data can be used to emphasize product effects on product detail pages and make advertisements, it is important to plan the clinical test from the development stage based on the product planning intention.

AIOLOZ leads the trend by offering business-customized All-In-One clinical tests.

So Min, Kang, Ph.D. Korea Biomedical research Institute CEO / Ph. D.
Principle Investigator
Dong Keon, Yon / M.D., Ph. D.

• PI of KBI
• Deputy Director of Kyung Hee Center for Digital Health
• Medicine Assistant Professor of College of Medicine, Kyung Hee University
• Last 3 years Published paper: 36 papers with IF 10 points¡è
- The Lancet, 2022, 400(10347), 185-235: IF 202.731
- The Lancet, 2021, 398(10299), 503-521: IF 202.731
- The Lancet Psychiatry, 2021, 8(4), 271-272: IF 77.056
- The Lancet Psychiatry, 2021, 7(12), 1025-1031: IF 77.056
- The Lancet infectious diseases, 2022, 22(11), 1626-1647: IF 46.750
• Editor of 4 SCI journals: Plos One, BMC Pediatrics, BMC Pulmonary Medicine, World Journal of Pediatrics
• First Asian Fellow American Academy of Allergy Asthma and Immunology & Fellow American College of Allergy Asthma and Immunology(FAAAAI & FACAAI)
• First Korean Mentor of European Academy of Allergy and Clinical Immunology(EAACI)
• Ranked 1st in the field of medicine for those who shiine Korea for 3 years (Theory)
• Ranked 1st in the field of medicine fo COVID-19 research in Korea (Hanbitsa)
• First Asian Rising Star Award, Young Medical Scientist Award (Clinical and Allergy) of American Thoracic Society

KBI Korean Biomedical Research Institute is a leading organization that combines the latest trends in dermatological clinical research with the highest level of expertise to evaluate the efficacy and safety for all of skin related products.

Under the supervision of medical and dermatological experts, KBI specializes in human application trials for skin related drugs, medical devices, health functional foods and cosmetics. With years of experience in skin clinical trials and dermatological research, KBI has a deep understanding of client needs and challenges. Additionally, by offering a wide range of testing options, KBI guarantees professionalism and accuracy while providing transparent and objective clinical trial data.

Directions

(13201) °æ±âµµ ¼º³²½Ã Áß¿ø±¸ »ç±â¸·°ñ·Î 99 (»ó´ë¿øµ¿)
¼¾Æ®·²ºñÁö 2Â÷ Bµ¿ 10Ãþ 1002È£~1005È£

(13201) 1002~1005, 10F, 99, Sagimakgol-ro, Jungwon-gu, Seongnam-si, Gyeonggi-do, Republic of Korea